BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19560801)

  • 1. Young patients with endometrial cancer: how many could be eligible for fertility-sparing treatment?
    Navarria I; Usel M; Rapiti E; Neyroud-Caspar I; Pelte MF; Bouchardy C; Petignat P
    Gynecol Oncol; 2009 Sep; 114(3):448-51. PubMed ID: 19560801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer.
    Zivanovic O; Carter J; Kauff ND; Barakat RR
    Gynecol Oncol; 2009 Dec; 115(3):504-9. PubMed ID: 19758691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian preservation and staging in reproductive-age endometrial cancer patients.
    Richter CE; Qian B; Martel M; Yu H; Azodi M; Rutherford TJ; Schwartz PE
    Gynecol Oncol; 2009 Jul; 114(1):99-104. PubMed ID: 19410280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexisting ovarian malignancy in young women with endometrial cancer.
    Walsh C; Holschneider C; Hoang Y; Tieu K; Karlan B; Cass I
    Obstet Gynecol; 2005 Oct; 106(4):693-9. PubMed ID: 16199623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma.
    Diaz JP; Sonoda Y; Leitao MM; Zivanovic O; Brown CL; Chi DS; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2008 Nov; 111(2):255-60. PubMed ID: 18755500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of endometrial carcinoma patients aged 45 years and younger].
    Gao JS; Shen K; Lang JH; Huang HF; Pan LY; Wu M; Jin Y; Chen QH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):159-61. PubMed ID: 15130373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial adenocarcinoma in young patients: evaluation and fertility-preserving treatment.
    Benshushan A
    Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):132-7. PubMed ID: 15541846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How many ovarian cancer patients are eligible for fertility-sparing surgery?
    Huber D; Cimorelli V; Usel M; Bouchardy C; Rapiti E; Petignat P
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):270-4. PubMed ID: 23886771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma.
    Neubauer NL; Havrilesky LJ; Calingaert B; Bulusu A; Bernardini MQ; Fleming ND; Bland AE; Secord AA
    Gynecol Oncol; 2009 Mar; 112(3):511-6. PubMed ID: 19144394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative surgical management of stage IA endometrial carcinoma for fertility preservation.
    Mazzon I; Corrado G; Masciullo V; Morricone D; Ferrandina G; Scambia G
    Fertil Steril; 2010 Mar; 93(4):1286-9. PubMed ID: 19700153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexisting endometrial and ovarian carcinomas: a retrospective clinicopathological study.
    Caldarella A; Crocetti E; Taddei GL; Paci E
    Pathol Res Pract; 2008; 204(9):643-8. PubMed ID: 18472354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.
    Ushijima K; Yahata H; Yoshikawa H; Konishi I; Yasugi T; Saito T; Nakanishi T; Sasaki H; Saji F; Iwasaka T; Hatae M; Kodama S; Saito T; Terakawa N; Yaegashi N; Hiura M; Sakamoto A; Tsuda H; Fukunaga M; Kamura T
    J Clin Oncol; 2007 Jul; 25(19):2798-803. PubMed ID: 17602085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative management of young patients with endometrial highly-differentiated adenocarcinoma.
    Kalogiannidis I; Agorastos T
    J Obstet Gynaecol; 2011; 31(1):13-7. PubMed ID: 21280986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
    Hurst SA; Hartzfeld KM; Del Priore G
    Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and long-term outcome of young patients with gastric carcinoma according to sex: does hormonal status affect prognosis?
    Kim JH; Boo YJ; Park JM; Park SS; Kim SJ; Kim CS; Mok YJ
    Arch Surg; 2008 Nov; 143(11):1062-7; discussion 1067. PubMed ID: 19015464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical observation of young, middle-aged and elderly women with endometrial carcinoma].
    Dai FR; Peng GQ; Zhang Y; Chen CX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):690-3. PubMed ID: 16708811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial cancer and fertility.
    Rackow BW; Arici A
    Curr Opin Obstet Gynecol; 2006 Jun; 18(3):245-52. PubMed ID: 16735822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
    Havrilesky LJ; Secord AA; O'Malley DM; Broadwater G; Bae-Jump V; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Aug; 114(2):279-83. PubMed ID: 19446319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sparing fertility in young patients with endometrial cancer.
    Chiva L; Lapuente F; González-Cortijo L; Carballo N; García JF; Rojo A; Gonzalez-Martín A
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S101-4. PubMed ID: 18804267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.